Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/5/2009

which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contact:    William R. LaRue
                SVP & Chief Financial Officer
                Cadence Pharmaceuticals, Inc.
                Phone : 858-436-1400



                           CADENCE PHARMACEUTICALS, INC.
                           (a development stage company)
                        CONDENSED STATEMENTS OF OPERATIONS
                                    (unaudited)

                          Three Months Ended          Nine Months Ended
                             September 30,              September 30,
                          ------------------          -----------------
                          2009          2008          2009         2008
                          ----          ----          ----         ----
    Operating expenses:
      Research and
       development     $4,924,778   $10,241,943   $15,144,099   $32,463,211
      Sales and
       marketing        2,608,441       664,143     4,330,695     2,175,120
      General and
       administrative   3,762,851     2,754,064     9,549,203     8,323,996
      Other                  (944)          509       412,141        28,766
                             ----           ---       -------        ------
        Total
         operating
         expenses      11,295,126    13,660,659    29,436,138    42,991,093
                       ----------    ----------    ----------    ----------

    Loss from
     operations       (11,295,126)  (13,660,659)  (29,436,138)  (42,991,093)

    Other (
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
3. Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
4. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
8. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
9. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
11. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to announce that ... at North Carolina State’s College of Veterinary Medicine has ... for Distinguished Volunteer Service—the organization’s highest award. , ... volunteer experts to direct its work to improve the ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on Thursday, ... of the Supreme Court decision Roe v. Wade, which legalized abortion ... Roe vs. Wade decision and the fight to protect a women’s ... of West Hollywood Councilmember Abbe Land. “We need to continue to ...
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering ... follow it on Facebook, Twitter, and Pinterest. The fans will ... draws a lottery every week. , Moreover, the company has ... Click Angelweddingdress homepage for more information. , ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... to Keep Kids from Smoking,Save Lives, Statement ... Kids, WASHINGTON, Nov. 5 North Dakota ... kids and health by approving,Measure 3, a state ... lower health care costs by increasing funding for ...
... Education has found its way onto the soccer fields ... experiment that may have all the right ingredients to change ... , Despite overall advances in medical care and treatment, Latinos ... than whites, a medical fact especially significant in North Carolina, ...
... Fayette,County,s largest employers will expand and create more than ... 20-year investment by the commonwealth., Uniontown Hospital will ... Redevelopment Authority, on behalf of the Fayette Regional,Health System, ... used to jump start the construction of a new,inpatient ...
... eye care facility in Tanzania to,be honored with ... Nov. 5 Today, Seva,Foundation proudly honors the ... preventable blindness around the world -- Dr. Paul,Courtright ... Center for Community Ophthalmology (KCCO),which Courtright and Lewallen ...
... in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine ... jetlag in passengers by nearly 50 percent. The two-part ... scoring system, showed Pycnogenol lowered symptoms of jetlag such ... both healthy individuals and hypertensive patients. Passengers also experienced ...
... Life,(AUL) today released analysis of the results of ... initiatives on,abortion defeated in California, Colorado, and South ... and,destructive embryonic stem cell research in Michigan were ... of AUL said: "We applaud the work,of those ...
Cached Medicine News:Health News:North Dakota Votes to Keep Promise to Kids by Fully Funding Tobacco Prevention 2Health News:New HIV-reduction initiative takes to the fields 2Health News:New HIV-reduction initiative takes to the fields 3Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 3Health News:Study shows pine bark reduces jetlag 2Health News:Study shows pine bark reduces jetlag 3Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 2Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 3
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... 13, 2011 Science, public health, and regulatory highlights ... in this document is designed for credentialed journalists. Release dates ... 2011. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... regulatory or enforcement actions due to legal limitations. ...
... Md., June 13, 2011 The Foundation for the National ... Management Systems Society (HIMSS) and the National Institutes of Health ... research, technology, business and policy for the 2011 mHealth Summit. ... the mHealth Alliance, HIMSS and NIH, the 3rd annual mHealth ...
Cached Medicine Technology:2011 mHealth Summit: Call for Research Abstracts and Speakers Now Open 22011 mHealth Summit: Call for Research Abstracts and Speakers Now Open 32011 mHealth Summit: Call for Research Abstracts and Speakers Now Open 4
Inquire...
Inquire...
...
... on decades of experience, the SSD-1000 is ... system. It uses our advanced technologies and ... Using the same technology as our more ... capabilities in a compact and mobile setting., ...
Medicine Products: